The frequency with which human papillomavirus (HPV) sequences are found in the general population, the prospective demonstration of a high rate of regression of infections with "high risk" HPV types, and the occurrence of HPV negative tumours suggest that HPV infection alone is not responsible for cervical neoplasia. Several co-factors have been identified by epidemiological means and others suggested by experimental observation (table) : analysis of these co-factors gives insight not only into the other steps involved in carcinogenesis, but also into the possible mechanism of action of HPVs.
Introduction
The frequency with which human papillomavirus (HPV) sequences are found in the general population, the prospective demonstration of a high rate of regression of infections with "high risk" HPV types, and the occurrence of HPV negative tumours suggest that HPV infection alone is not responsible for cervical neoplasia. Several Studies of the cooperation between HPV genes and oncogenes in the transformation of normal cells have been performed using both rodent and human cells. The HPV 16 early (E)6 and E7 genes, under the control of a heterologous promoter, can immortalise primary baby rat kidney (BRK) cells and, with the cooperation of the activated H-ras gene, transform them such that they are tumourigenic in syngeneic animals.' Using the same (BRK) cells, it was also shown that the E7 gene, controlled by the SV40 promoter, has transforming ability in association with activated H-ras-1 and that this function is conferred by the E7 gene product.2 These studies were extended to other HPV types (HPV 6, 11, 18, 31, and 33) and showed that HPV 16, 18, 31, and 33, but not HPV 6 and 11, were capable of cooperating with activated H-ras in the transformation of BRK cells.' The E7 genes from HPV 6 and 11 were subsequently shown to be capable of cooperating with H-ras-1 but only under the control of a strong promoter and with an efficiency 50 to 100-fold lower than that of the HPV 16 E7 gene. 4 can cooperate with c-fos but not c-myc, v-fins, v-mos, c-src, or p53.6 However, the E7 gene product is not as efficient as the whole early gene region in transforming primary cultures in association with activated H-ras, suggesting that other viral early genes are required for efficient transformation.
A modification of the two step approach used for the study of rodent cells has been applied to primary human cells.8 These cells were transfected with HPV 16 in association with a strong promoter with or without activated H-ras. In both circumstances the life span of the cells was extended but, after treatment with HPV 16 alone, the cells remained diploid with normal morphology. When activated H-ras was also transfected, the cells became aneuploid, with a modal chromosome number of 85-88, were morphologically more refractile, and became independent of serum with an enhanced growth rate. In the absence of activated H-ras the cells were not tumourigenic, whereas after co-transfection, benign tumour nodules were produced. More specifically, cytogenetic analysis of co-transfected cells showed that translocations involving chromosomes 1 and 11 (particularly t(1:11) (ql2:q23)) were common. This observation is of relevance in the light of the localisation of H-ras-1 to chromosome 11 and the postulated role of chromosome 11 in cervical neoplasia.
These studies show that HPV sequences induce immortalisation and are capable of cooperation with known oncogenes in vitro. immunostaining have also produced conflicting results, with several workers reporting staining of the basal layers of inflammatory cervical lesions, condylomata, and low grade cervical intraepithelial neoplasia (CIN), and p53 positivity of HPV positive tumours. However, the equation of p53 immunostaining with p53 gene mutation is unlikely to be valid and these studies should be interpreted with caution.2' Nevertheless, the coexistence of p53 mutations and HPV infection does not preclude a role for E6/p53 binding in cervical carcinogenesis as p53 mutation may occur as a secondary event in these tumours. The demonstration of p53 mutation in metastases from an HPV positive carcinoma would support this possibility,22 suggesting that acquisition of further genetic abnormalities may be involved in tumour progression.
Mechanistically, the immortalisation of cells by HPV 16 E6/E7 abrogates the increase in p53 expression and reduction in DNA synthesis induced by actinomycin D23 and HPV 18 E6 inhibits p53 dependent enhancement of transcription after ultraviolet irradiation. 24 Similarly, the presence of E6 from HPV 16, but not that from HPV 6, reduced the ability of p53 to stimulate transcription and this property is also possessed by mutant p53.25 Thus, p53 mutation and inactivation are in some respects biologically similar. However, mutant p53 has immortalising ability but does not possess the transactivating or transforming functions of E6.26 Conversely, it is theoretically possible for the cell to overcome the effects of E6 on p53 by synthesising more p53 protein, whereas the effect of a p53 mutation is irreversible. However, the failure of artificially increasing wild-type p53 protein in HPV immortalised cells to reverse the immortalisation process does not support this contention. 27 Nevertheless, cooperation of HPV 18 E6 with c-myc and H-ras appears to be necessary for the complete functional inactivation of wild-type p53 in NIH-3T3 cells, suggesting that other genetic events are required. 28 A p53 mutation cannot always be demonstrated in HPV negative tumours29 and, although it is important to exclude the possibility that these tumours contain uncharacterised HPV types not detected by the HPV assay used, it seems likely that mechanisms other than p53 mutation/inactivation are important in some tumours. THE 
RETINOBLASTOMA GENE
The E7 proteins of HPV 16 and 18 bind to the hypophosphorylated form of the product of the retinoblastoma gene (Rb), the prototype tumour suppressor gene30; this binding leads to dissociation of Rb from the transcription factor E2F. The E7 protein also binds to histone Hi kinase and to p107,3' emphasising its potential to interfere with cell cycle control.
Activated oncogenes can therefore cooperate with HPV sequences in the transformation of primary human cells and HPV infection with "high risk" types abrogates the function of well characterised tumour suppressor genes. Indeed, a single HPV infection is equivalent to multiple genetic events, early genes having dominant transforming function as well as the ability of E6 and E7 to bind to p53 and Rb proteins being functionally equivalent to the loss of both alleles. These actions may explain the strength of the association of cervical neoplasia with HPV infection. 16 in the transformation of primary BRK cells,39 while oestrogens had no effect. Cell lines produced in this way were capable of producing tumours in syngeneic animals. Therefore, there is experimental evidence for endocrine modulation of HPV infection in the genesis of cervical neoplasia.
Chromosome aberrations
Chromosome abnormalities, particularly of chromosomes 1 and 11, can be induced in human cells by cotransfection with HPV DNA and activated H-ras8 and in raft cultures.32 Cytogenetic analysis of cervical tumours has shown that chromosomes 1, 3, 11, and 17 are often abnormal33 and transformation is associated with non-random aberrations involving chromosomes 1, 11, 19, and 20.34 It is possible that changes in gene dosage by chromosome loss, duplication, or rearrangement following induction of aneuploidy might lead to inactivation of cellular tumour suppressor genes such as
Smoking
There are limited data regarding the interaction of smoking and HPV infection, but the finding of reduced numbers of Langerhans' cells in cervical epithelium in smokers suggests that reduced presentation of viral antigen may occur, resulting in viral persistence.40
The prevalence of HPV is related to smoking history and there is a dose response relationship. 4 It has emerged recently that the prevalence of HIA DQw3 is greater in patients with cervical carcinoma than in the control population. 54 This suggests that some class II HIA antigens may be associated with increased susceptibility to cervical carcinoma, although this association was not found by others. 55 There are, however, some data showing that the association is stronger between HIA DQw3 and HPV infection than between it and the degree of CIN or invasive carcinoma,56 suggesting that patients who are HIA DQw3 positive may be at greater risk of cervical neoplasia because of a reduced ability to clear HPV infection.
An increased incidence of CIN has been described in patients who have received renal transplants: in one study mean lag time to condylomatous change was 22A4 months and to CIN or invasive cancer 38-0 months.57 The transient immunosuppression which occurs in pregnancy is associated with an increased incidence of genital warts and CIN lesions, and a higher prevalence of HPV in cervical smears. 58 More recently, an increased risk of cervical neoplasia has been noted in patients infected with HIV and the severity and duration of viral warts are similarly increased. The prevalence of HPV is increased in HIV positive patients, particularly if they are not immunocompetent as assessed by CD4 count59; HPV associated epithelial abnornalities are more common in immunosuppressed HIV positive patients. Interaction between HPV and HIV has been demonstrated in vitro with the tat-i protein of HIV capable of enhancing E2 dependent HPV 16 transcription60: this provides a potential mechanism for interaction between these agents and suggests that the interaction may occur in two separate waysthat is, by immunosuppression and by direct alteration of gene transcription. The importance of HPV in the genesis of cervical neoplasia suggests that diagnosis of a particular HPV infection would dictate a particular clinical outcome and hence be useful in patient management. However, HPV infection occurs early and is neither necessary nor sufficient for oncogenesis. Indeed, HPV negative cervical carcinomas appear to have a worse prognosis than HPV positive ones. 12 There are however several possible areas in which HPV analysis may be of clinical value, two of which will be highlighted here.
CERVICAL SCREENING
The principles of screening involve the application of a simple, cheap, effective test to a high risk population. The evidence that CIN lesions are a precursor to invasive cancer forms the basis of the screening programme, the premise being that the detection and treatment of these lesions prevents progression to invasive disease. The rationale behind screening the whole female population is that no individual epidemiological risk factor is of sufficient magnitude to warrant the identification of subgroups of women. 
